Pentasa is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Carilion Materials Management. The primary component is Mesalamine.
Product ID | 68151-4769_7eba11c1-f784-4bf4-b66f-c3f66fd634c9 |
NDC | 68151-4769 |
Product Type | Human Prescription Drug |
Proprietary Name | Pentasa |
Generic Name | Mesalamine |
Dosage Form | Capsule |
Route of Administration | ORAL |
Marketing Start Date | 1993-05-10 |
Marketing Category | NDA / NDA |
Application Number | NDA020049 |
Labeler Name | Carilion Materials Management |
Substance Name | MESALAMINE |
Active Ingredient Strength | 250 mg/1 |
Pharm Classes | Aminosalicylate [EPC],Aminosalicylic Acids [CS] |
NDC Exclude Flag | E |
Listing Certified Through | 2018-12-31 |
Marketing Start Date | 1993-05-10 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA020049 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 1993-05-10 |
Inactivation Date | 2020-01-31 |
Ingredient | Strength |
---|---|
MESALAMINE | 250 mg/1 |
SPL SET ID: | ec53b1d4-b98d-4b4d-acc3-199f98031966 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
68151-4769 | Pentasa | Pentasa |
69189-0189 | Pentasa | Pentasa |
54092-189 | Pentasa | Pentasa |
54092-191 | Pentasa | Pentasa |
0023-5901 | Asacol HD | mesalamine |
0430-0783 | ASACOL HD | mesalamine |
0023-5853 | Delzicol | mesalamine |
0179-0142 | Lialda | mesalamine |
0093-5907 | Mesalamine | Mesalamine |
0093-9224 | mesalamine | mesalamine |
0378-1375 | Mesalamine | mesalamine |
0378-9230 | Mesalamine | mesalamine |
0472-1915 | Mesalamine | Mesalamine |
0037-0066 | Rowasa | mesalamine |
0037-0022 | sfRowasa | mesalamine |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
PENTASA 76705752 4007879 Live/Registered |
Ferring B.V. 2010-12-22 |
PENTASA 73365906 1279563 Live/Registered |
Farmaceutisk Laboratorium Ferring A/S 1982-05-21 |